In the article listed above, there is an error in Fig. 3. In panel B, the immunohistochemical staining of insulin (top middle panel) is incorrect. The corrected Fig. 3 appears below.

Figure 3
Figure 3. BM morphology at 1 year posttransplantation. Photomicrographs of BM biopsy samples from patient 3. A: Histological appearance (left panel, magnification 200x; right panel, inset of left panel, magnification 400x) of transplanted tissue. Hematoxylin and eosin staining. B: Representative immunohistochemical stainings (magnification 200x) with anti-insulin, antiglucagon, antichromogranin A, antisomatostatin, antipancreatic polypeptide, and anti-CD34 antibodies.
View largeDownload slide

BM morphology at 1 year posttransplantation. Photomicrographs of BM biopsy samples from patient 3. A: Histological appearance (left panel, magnification 200x; right panel, inset of left panel, magnification 400x) of transplanted tissue. Hematoxylin and eosin staining. B: Representative immunohistochemical stainings (magnification 200x) with anti-insulin, antiglucagon, antichromogranin A, antisomatostatin, antipancreatic polypeptide, and anti-CD34 antibodies.

Figure 3
Figure 3. BM morphology at 1 year posttransplantation. Photomicrographs of BM biopsy samples from patient 3. A: Histological appearance (left panel, magnification 200x; right panel, inset of left panel, magnification 400x) of transplanted tissue. Hematoxylin and eosin staining. B: Representative immunohistochemical stainings (magnification 200x) with anti-insulin, antiglucagon, antichromogranin A, antisomatostatin, antipancreatic polypeptide, and anti-CD34 antibodies.
View largeDownload slide

BM morphology at 1 year posttransplantation. Photomicrographs of BM biopsy samples from patient 3. A: Histological appearance (left panel, magnification 200x; right panel, inset of left panel, magnification 400x) of transplanted tissue. Hematoxylin and eosin staining. B: Representative immunohistochemical stainings (magnification 200x) with anti-insulin, antiglucagon, antichromogranin A, antisomatostatin, antipancreatic polypeptide, and anti-CD34 antibodies.

Close modal

The online version reflects these changes.

View Original Article
© 2014 by the American Diabetes Association.
2014
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.